US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Perpetuals.com Ltd

3.30

-0.0500-1.49%

Pre-market: 3.29-0.0100-0.30%04:00 EDT

Volume:15.14K

Turnover:49.09K

Market Cap:26.78M

PE:-0.66

High:3.52

Open:3.52

Low:3.17

Close:3.35

52wk High:8.83

52wk Low:2.42

Shares:8.11M

Float Shares:5.45M

Volume Ratio:1.08

T/O Rate:0.28%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.9964

EPS(LYR):-0.7902

ROE:-72.52%

ROA:-8.93%

PB:1.12

PE(LYR):-4.18

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Perpetuals.com UpsideOnly Registered User Base Reaches 600,000 in 38 Days

Press Release: Avacta Group Plc: Interim Results for the Six Months to June 30, 2026, and Business Update

Avacta Group plc: The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic Cancer

Avacta Achieves Clinical Proof of Mechanism for the Next Generation of pre|CISION® Medicines with AVA6103 (FAP-Exd) in the Phase 1 FOCUS-01 Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/PDC"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PDC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PDC\",,,,,undefined,":{"symbol":"PDC","market":"US","secType":"STK","nameCN":"Perpetuals.com Ltd","latestPrice":3.3,"timestamp":1791403200000,"preClose":3.35,"halted":0,"volume":15143,"hourTrading":{"tag":"盘前","latestPrice":3.29,"preClose":3.3,"latestTime":"04:00 EDT","volume":47,"amount":154.63,"timestamp":1791446404610,"change":-0.01,"changeRate":-0.00303,"amplitude":0},"delay":0,"changeRate":-0.014925373134328438,"floatShares":5452700,"shares":8114100,"eps":-4.996365,"marketStatus":"Pre-Mkt","change":-0.05,"latestTime":"10-08 06:11:09 EDT","open":3.52,"high":3.52,"low":3.17,"amount":49086.2419591,"amplitude":0.104478,"askPrice":3.88,"askSize":100,"bidPrice":2.89,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.996365,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791466200000},"marketStatusCode":1,"adr":0,"adrRate":5,"listingDate":1690257600000,"exchange":"NASDAQ","adjPreClose":3.3,"preHourTrading":{"tag":"盘前","latestPrice":3.29,"preClose":3.3,"latestTime":"04:00 EDT","volume":47,"amount":154.63,"timestamp":1791446404610,"change":-0.01,"changeRate":-0.00303,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":3.3,"preClose":3.3,"latestTime":"19:30 EDT","volume":4,"amount":12.98,"timestamp":1791415801099,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.081442004781602},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PDC\",,,,,undefined,":{"symbol":"PDC","floatShares":5452700,"roa":"-8.93%","roe":"-72.52%","lyrEps":-0.790182,"volumeRatio":1.081442004781602,"shares":8114100,"dividePrice":0,"high":3.52,"amplitude":0.104478,"preClose":3.35,"low":3.17,"week52Low":2.42,"pbRate":"1.12","psRate":"16.54","week52High":8.83,"institutionHeld":0,"latestPrice":3.3,"eps":-4.996365,"divideRate":0,"volume":15143,"delay":0,"ttmEps":-4.996365,"open":3.52,"prevYearClose":6.475,"prevWeekClose":3.46,"prevMonthClose":3.34,"prevQuarterClose":3.34,"fiveDayClose":3.34,"twentyDayClose":3.15,"sixtyDayClose":4.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PDC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-16","symbol":"PDC","defaultRemindTime":1715866200000,"type":"split","dateTimestamp":1715832000000,"forFactor":5,"toFactor":1,"ratio":5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PDC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PDC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PDC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PDC","date":"2026-10-07","current":-0.66048,"percent":0.960452,"low":-20.799035,"twenty":-13.623956,"median":-9.463019,"eighty":-7.598483,"high":-1.484564,"avg":-9.909224,"sd":3.587923,"marketCap":27182362},"quantilePoints":[{"date":"2026-01-23","current":-12.841505,"twenty":-12.726719,"median":-12.554539,"eighty":-12.382359,"marketCap":20820140},{"date":"2026-01-30","current":-9.396756,"twenty":-12.329049,"median":-11.675543,"eighty":-10.201718,"marketCap":15771446},{"date":"2026-02-06","current":-7.275042,"twenty":-12.149167,"median":-9.714799,"eighty":-8.086801,"marketCap":11897223},{"date":"2026-02-13","current":-8.985188,"twenty":-11.515878,"median":-8.985188,"eighty":-7.549471,"marketCap":15130827},{"date":"2026-02-20","current":-8.855994,"twenty":-10.87722,"median":-8.985188,"eighty":-7.579088,"marketCap":14673241},{"date":"2026-02-27","current":-8.742983,"twenty":-10.032842,"median":-8.830662,"eighty":-7.735212,"marketCap":14368184},{"date":"2026-03-06","current":-9.337263,"twenty":-10.032842,"median":-8.985188,"eighty":-8.021273,"marketCap":15191838},{"date":"2026-03-13","current":-9.688387,"twenty":-9.991079,"median":-9.288813,"eighty":-8.290652,"marketCap":15618918},{"date":"2026-03-20","current":-9.233278,"twenty":-9.991079,"median":-9.314811,"eighty":-8.348912,"marketCap":14993551},{"date":"2026-03-27","current":-9.069316,"twenty":-9.96573,"median":-9.348389,"eighty":-8.474222,"marketCap":14581724},{"date":"2026-04-02","current":-9.313761,"twenty":-9.884139,"median":-9.348389,"eighty":-8.689231,"marketCap":15008804},{"date":"2026-04-10","current":-9.533008,"twenty":-9.74834,"median":-9.359515,"eighty":-8.70742,"marketCap":15374872},{"date":"2026-04-17","current":-12.673274,"twenty":-9.884139,"median":-9.362202,"eighty":-8.546978,"marketCap":20438819},{"date":"2026-04-24","current":-13.088049,"twenty":-10.217704,"median":-9.396756,"eighty":-8.70742,"marketCap":21079438},{"date":"2026-05-01","current":-15.050104,"twenty":-11.793949,"median":-9.471088,"eighty":-8.745021,"marketCap":24648605},{"date":"2026-05-08","current":-14.948137,"twenty":-12.890814,"median":-9.496239,"eighty":-8.793369,"marketCap":24526582},{"date":"2026-05-15","current":-13.305836,"twenty":-13.354923,"median":-9.542177,"eighty":-8.845861,"marketCap":21598035},{"date":"2026-05-22","current":-11.365513,"twenty":-13.169042,"median":-9.675854,"eighty":-8.876909,"marketCap":21140450},{"date":"2026-05-29","current":-14.128136,"twenty":-13.74972,"median":-9.719101,"eighty":-8.895541,"marketCap":26275960},{"date":"2026-06-05","current":-12.076178,"twenty":-13.8801,"median":-9.813125,"eighty":-8.952904,"marketCap":22349404},{"date":"2026-06-12","current":-14.872027,"twenty":-13.8801,"median":-9.991079,"eighty":-9.00144,"marketCap":27440229},{"date":"2026-06-18","current":-14.520969,"twenty":-14.245743,"median":-10.18842,"eighty":-9.035091,"marketCap":26709707},{"date":"2026-06-26","current":-11.614912,"twenty":-14.356284,"median":-10.79484,"eighty":-9.128052,"marketCap":21276450},{"date":"2026-07-02","current":-13.769243,"twenty":-14.446364,"median":-10.952611,"eighty":-9.21958,"marketCap":25339979},{"date":"2026-07-10","current":-12.205639,"twenty":-14.446364,"median":-11.365513,"eighty":-9.239186,"marketCap":32585522},{"date":"2026-07-17","current":-8.962642,"twenty":-14.389601,"median":-10.952611,"eighty":-9.21958,"marketCap":23914115},{"date":"2026-07-24","current":-9.476284,"twenty":-14.254526,"median":-10.71246,"eighty":-9.09917,"marketCap":25065786},{"date":"2026-07-31","current":-9.145848,"twenty":-14.247303,"median":-10.285858,"eighty":-9.069924,"marketCap":24862550},{"date":"2026-08-07","current":-7.600862,"twenty":-14.243402,"median":-10.102078,"eighty":-8.962642,"marketCap":20797828},{"date":"2026-08-14","current":-7.895877,"twenty":-14.128136,"median":-9.96573,"eighty":-8.855994,"marketCap":21475282},{"date":"2026-08-21","current":-7.890223,"twenty":-13.901725,"median":-9.813125,"eighty":-8.565167,"marketCap":21543027},{"date":"2026-08-28","current":-7.54419,"twenty":-13.86583,"median":-9.719101,"eighty":-8.219559,"marketCap":20526847},{"date":"2026-09-04","current":-6.589647,"twenty":-13.865684,"median":-9.68212,"eighty":-8.074037,"marketCap":18358995},{"date":"2026-09-11","current":-7.149765,"twenty":-13.859725,"median":-9.551961,"eighty":-7.894746,"marketCap":20120374},{"date":"2026-09-18","current":-7.670838,"twenty":-13.787041,"median":-9.54288,"eighty":-7.752526,"marketCap":21340182},{"date":"2026-09-25","current":-1.685972,"twenty":-13.740832,"median":-9.505721,"eighty":-7.700224,"marketCap":29210896},{"date":"2026-10-02","current":-1.607699,"twenty":-13.684675,"median":-9.492422,"eighty":-7.615276,"marketCap":27993776},{"date":"2026-10-07","current":-1.567622,"twenty":-13.623956,"median":-9.463019,"eighty":-7.598483,"marketCap":27182362}],"updateTime":1791454269275},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PDC\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672754421","title":"Perpetuals.com UpsideOnly Registered User Base Reaches 600,000 in 38 Days","url":"https://stock-news.laohu8.com/highlight/detail?id=2672754421","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672754421?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:00","pubTimestamp":1790856058,"startTime":"0","endTime":"0","summary":"Perpetuals.com UpsideOnly registered user base reaches 600,000 in 38 daysPerpetuals.com’s UpsideOnly paper-trading platform topped 600,000 registered users on Sept. 26, doubling from 300,000.Added abo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDLc1qfyS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671320189","title":"Press Release: Avacta Group Plc: Interim Results for the Six Months to June 30, 2026, and Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2671320189","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671320189?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:00","pubTimestamp":1790769600,"startTime":"0","endTime":"0","summary":"LONDON and PHILADELPHIA, Sept. 30, 2026  -- Avacta Therapeutics , a life sciences company developing innovative, targeted oncology drugs, today publishes its unaudited interim results for the six months ended June 30, 2026 .H1 highlights and post periodResearch & developmentNext Generation pre|CISION pipeline-- AVA6103 . -- Preliminary preclinical and clinical data with AVA6103 have been. presented recently. Data reported in the Phase 1a trial in. patients with select solid tumors demonstrate proof of mechanism. demonstrates a clean safety profile through the first three. dose levels, including a payload dose level 50% higher than. -- The comparison of the preclinical modeled pharmacokinetic.  data and clinical trial PK data demonstrates an. exceptional alignment through the first 3 dose levels with. controlled release of exatecan evident in patients for days. -- The first head-to-head preclinical comparison of AVA6103 and. Enhertu, a marketed antibody drug conjugate  that targets. HER","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4567","MTD","BK4022","LU2413666426.HKD","BK4123","BK4585","LU2413666699.HKD","LU1093756168.USD","LU2211817866.USD","KBWY","IE00BFXG0V08.USD","LU1093756325.SGD","BK4218","LU1721428933.USD","PDC","BK4181","BK4231","IE00BYQQ9H92.USD","R","BK4588","AVCTF","NETL","BK4232","LU0347712357.USD","IE00B5TLWC47.USD","BK4080","IND","PK","BK4548","ADC","BK4121","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670482204","title":"Avacta Group plc: The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670482204","media":"GlobeNewswire","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670482204?lang=en_us&edition=fundamental","pubTime":"2026-09-25 14:00","pubTimestamp":1790316000,"startTime":"0","endTime":"0","summary":"LONDON and PHILADELPHIA, Sept.  25, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, the \"Company\", \"Avacta\"), a life sciences company developing innovative, targeted oncology drugs, today ann","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/25/3368853/0/en/avacta-group-plc-the-focus-01-clinical-trial-design-and-preclinical-data-further-demonstrate-the-potential-of-ava6103-at-aacr-conference-on-pancreatic-cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0828238088.HKD","MTD","BK4108","BK4509","LU1023057109.AUD","IE00B5TLWC47.USD","BK4585","LU0347712357.USD","NETL","BK4218","BK4565","BK4548","LU2211817866.USD","BK4588","BK4123","BK4571","IE00BYQNZ168.SGD","BK4567","IE00BYQQ9H92.USD","BK4533","BK4526","LU0269904917.USD","BK4121","PDX","BK4181","LU0359202008.SGD","IE00BFXG0V08.USD","KBWY","LU2413666699.HKD","LU0359201612.USD","LU2039709279.SGD","ADC","BK4552","IE00B12V2V27.USD","LU0456842615.SGD","PDC","LU0509642566.USD","LU1721428933.USD","PK","TME","BK4531","BK4563","LU2413666426.HKD","BK4080","BK4231","01698","IE00BYTNYN87.SGD","SG9999011746.SGD","LU1093756168.USD","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667984870","title":"Avacta Achieves Clinical Proof of Mechanism for the Next Generation of pre|CISION® Medicines with AVA6103 (FAP-Exd) in the Phase 1 FOCUS-01 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667984870","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667984870?lang=en_us&edition=fundamental","pubTime":"2026-09-16 23:00","pubTimestamp":1789570800,"startTime":"0","endTime":"0","summary":"LONDON and PHILADELPHIA, Sept.  16, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs, announces today that it has achiev","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/16/3363359/0/en/avacta-achieves-clinical-proof-of-mechanism-for-the-next-generation-of-pre-cision-medicines-with-ava6103-fap-exd-in-the-phase-1-focus-01-trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1721428933.USD","BK4123","BK4181","BK4567","BK4218","IE00BFXG0V08.USD","LU1169589451.USD","LU1093756325.SGD","LU1093756168.USD","BK4121","IE00B5TLWC47.USD","ADC","LU0347712357.USD","BK4023","PD","PDC","BK4080","LU1169590202.USD","BK4585","LU2413666699.HKD","LU2413666426.HKD","BK4231","BK4548","PK","BK4588","IE00BYQQ9H92.USD","LU2211817866.USD","MDCO","BK4533","KBWY","MTD","NETL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":17,"pageCount":1,"totalSize":67,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PDC\",params:#limit:6,delay:false,,,undefined,":[]}}